fbpx

Fund for New Research

New global therapy now approved for Australian patients with Leiomyosarcoma

An additional chemotherapy option for people with advanced leiomyosarcoma is now available on the Pharmaceutical Benefits Scheme (PBS). Trabectedin, (brand name - Yondelis) offers renewed hope for patients facing this rare and challenging sarcoma cancer. [...]

New global therapy now approved for Australian patients with Leiomyosarcoma2023-10-18T11:44:07+11:00

ANZGOG’s Endometrial Cancer Study Awarded $1.27 Million in Funding from the MRFF Grant

ANZGOG’s TAPER Study has received $1.27 million in funding from the Australian Government’s Medical Research Future Fund (MRFF) which aims to improve the health and wellbeing of Australians by supporting medical research and innovation.  [...]

ANZGOG’s Endometrial Cancer Study Awarded $1.27 Million in Funding from the MRFF Grant2023-10-18T11:50:42+11:00
Go to Top